Will Robbins

Who they are

Will Robbins is General Partner at Contrary — joined the fund in 2017 when it had ~$2M AUM and helped scale it to $250M+ across four funds, generating $10B+ in market cap from seed investments.

Person

Will joined Contrary in 2017 when it was a barely-there $2M AUM seed fund — he's been there for the full arc from near-zero to $250M+ across four funds and $10B+ in market cap created. Before that, he was a software developer focused on machine learning and infrastructure, a technical foundation that still shapes how he evaluates companies. Possibly — he built a mobile app that reached 100,000+ users by age 17, which would make him one of those rare investors who actually shipped consumer product before ever writing a check. His public voice on LinkedIn covers enterprise software disruption, ERP, AI, fintech, and healthtech — he posts with conviction, not curation, calling out category shifts like ERP's 35-year stagnation when championing DualEntry's $90M Series A. The through-line is a builder-turned-backer who got in early, stayed long, and bets on technical infrastructure shifts before the consensus forms.

Company

Contrary's most recent publicly visible deal is its participation in a $108 million Series A for Corgi in January 2026. As of December 2024, the firm managed approximately $288 million in assets under management. The Venture Partners program continues to scale — the Class of 2026 cohort selected 21 participants from over 1,700 applicants, signaling the talent-network flywheel is still a core part of the model. On the portfolio side, Memora Health was acquired in December 2024, and Momentum was acquired by Virtuous in August 2025. Contrary also released a 2026 Tech Trends Report covering computational intelligence, breakthrough biologics, and digital interfaces — a research publishing move that signals the firm is investing in brand and founder mindshare.

Market

Contrary competes in seed and early-stage venture, where its differentiation is a talent network (Contrary Talent, launched July 2020) and a Venture Partners program that recruits from top universities — a model that gives it deal flow most generalist funds can't replicate. The firm's portfolio spans enterprise software, AI infrastructure, fintech, and healthtech, putting it in direct competition with other multi-thesis seed funds. A Rubrik IPO at a $5.63 billion valuation in April 2024 is the marquee public proof point for the portfolio's upper end.

Network

Kyle Harrison is a fellow General Partner at Contrary, leading investing from seed to scale. No additional named edges are available from the sourced claims.

How they likely show up

  • Joined Contrary in 2017 at ~$2M AUM and stayed through $250M+ → thinks in fund cycles and long compounding arcs, not short-term optionality.
  • Background as a software developer in machine learning and infrastructure → likely evaluates technical architecture claims firsthand, not just through advisors.
  • Public LinkedIn posts call out specific structural dynamics (35 years of ERP stagnation, fixed income market structure) → forms strong theses and articulates them publicly, not a consensus follower.
  • Endorsed portfolio companies across ERP (DualEntry), fintech (Moment), and healthtech (Carda Health) → multi-thesis investor who tracks patterns across verticals rather than owning one lane.
  • Possibly — built a consumer app to 100,000+ users as a teenager → likely has direct empathy for founder execution risk and early distribution challenges.

Conversation tips

  • → Reference a specific portfolio bet — DualEntry's $90M Series A or Moment's $36M Series B — and ask about the thesis, not the company. He posts about structural market dynamics, so engage at that level.
  • → If you have a technical background, surface it early. His ML and infrastructure roots mean he'll calibrate differently to a founder or operator who can speak to the stack.
  • → Don't pitch the market size — he already knows it. Come in with a specific structural insight about why the incumbent is vulnerable right now.
  • → Ask about the Contrary talent network model and how it feeds deal flow — it's a distinctive part of the firm's identity and he'll have views on what makes it work.

Toolbox

Openers

  • Open on DualEntry's $90M Series A — he posted publicly that it signals the end of 35 years of ERP stagnation. Ask what made it the right moment to back that bet.
  • Reference the Contrary Venture Partners Class of 2026: 21 selected from 1,700 applicants. That talent-network flywheel is central to how the firm sources deals — it's a good entry point into how he thinks about proprietary deal flow.
  • Mention the Rubrik IPO at a $5.63 billion valuation in April 2024 — it's the portfolio's most visible public proof point and opens a conversation about what seed-stage signals he looks for that predicted that outcome.

Discovery questions

  1. You've been at Contrary since $2M AUM — how has your conviction framework for seed investments changed as the fund scaled to $250M+?
  2. Your posts on ERP disruption and fixed income tech suggest you look for categories with decades of structural underinvestment. What's the current version of that pattern you're watching?
  3. The Contrary Talent network is a big part of the model — how does operator and engineer density in that network actually change what you can do for a portfolio company post-investment?

Avoid

Don't open with generic AI investment themes — he posts with specific structural theses (ERP stagnation, fixed income market structure) and will disengage quickly from vague category enthusiasm.

Make it yours

Tailor these openers to what you sell

These openers are generic. Sign in and tell Brief what you sell — it rewrites the hooks and questions around your pitch.

Sources

Brief on your next meeting?

Type any name. Get a structured pre-meeting brief in seconds.

Try Brief →

Generated by briefthecall.com from public web sources on June 5, 2026. Each claim is linked to its source above.

Automatically generated by AI from public sources. May be inaccurate or out of date. Remove or correct this profile →